Last --
Change Today 0.00 / 0.00%
Volume 0.0
4549 On Other Exchanges
Symbol
Exchange
4549 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

eiken chemical co ltd (4549) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for EIKEN CHEMICAL CO LTD (4549)

Related News

No related news articles were found.

eiken chemical co ltd (4549) Related Businessweek News

No Related Businessweek News Found

eiken chemical co ltd (4549) Details

Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics and equipment in Japan. The company offers a range of in vitro diagnostic aids for various fields of medicine; reagents for various fields of clinical diagnostics, including microbiological, urinalysis, clinical chemistry, immunology, and serology; and microbiological reagents for food and environment inspections. It also offers immunochemical fecal occult blood tests for early identification of colon cancer; real time turbidimeter, amplification kits, fluorescence detection reagents, and detection kits in the field of molecular genetics; and products used in the field of microbiology. In addition, Eiken Chemical Co., Ltd. operates as an insurance agent; and is involved in the purchase and sale of OA equipment. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was founded in 1939 and is headquartered in Tokyo, Japan.

651 Employees
Last Reported Date: 06/23/14
Founded in 1939

eiken chemical co ltd (4549) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

eiken chemical co ltd (4549) Key Developments

Eiken Chemical Co., Ltd., Annual General Meeting, Jun 20, 2014

Eiken Chemical Co., Ltd., Annual General Meeting, Jun 20, 2014.

Eiken Chemical Co., Ltd., 2014 Earnings Call, Apr 30, 2014

Eiken Chemical Co., Ltd., 2014 Earnings Call, Apr 30, 2014

Eiken Chemical Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2014; Provides Consolidated and Non-Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2014; Declares Dividend for the Full Year of Fiscal 2014; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2015

Eiken Chemical Co., Ltd. reported consolidated and non-consolidated earnings results for the year ended March 31, 2014. For the period, on consolidated basis, net sales were JPY 32,027 million against JPY 28,605 million a year ago. Operating income was JPY 3,008 million against JPY 2,548 million a year ago. Net income was JPY 1,984 million or JPY 109.13 per diluted share against JPY 2,453 million or JPY 134.98 per diluted share a year ago. ROE was 8.3% against 10.9% a year ago. Cash flows from operating activities were JPY 3,410 million against JPY 2,228 million a year ago. The company announced dividend of JPY 20.00 per share for the end of fourth quarter ended March 31, 2014 compared to dividend of JPY 20.00 per share paid for the same period a year ago. The dividend is payable on June 3, 2014. The company provided dividend guidance for the end of second quarter and for the end of fourth quarter of fiscal year ending March 31, 2015. The company expects to pay dividend of JPY 17.00 per share for the end of second quarter of fiscal year ending March 31, 2015. The company expects to pay dividend of JPY 18.00 per share for the end of fourth quarter of fiscal year ending March 31, 2015 compared to dividend of JPY 20.00 per share paid for the same period a year ago. The company provided consolidated and non-consolidated earnings guidance for the first half and full year of fiscal year ending March 31, 2014. For the first half, on consolidated basis, the company expects net sales of JPY 15,970 million, operating income of JPY 1,570 million and net income was JPY 1,010 million or JPY 55.52 per diluted share. For the full year, on consolidated basis, the company expects net sales of JPY 31,320 million, operating income of JPY 2,900 million and net income was JPY 1,870 million or JPY 102.79 per diluted share. For the period, on non-consolidated basis, net sales were JPY 30,026 million against JPY 28,626 million a year ago. Operating income was JPY 3,011 million against JPY 2,575 million a year ago. Net income was JPY 1,959 million or JPY 107.73 per diluted share against JPY 2,401 million or JPY 132.15 per diluted share a year ago. Net assets per share as on March 31, 2014 was JPY 1,373.55 compared to JPY 1,309.75 as at March 31, 2013. For the first half, on non-consolidated basis, the company expects net sales of JPY 15,910 million, operating income of JPY 1,600 million and net income was JPY 1,030 million or JPY 56.62 per diluted share. For the full year, on non-consolidated basis, the company expects net sales of JPY 31,120 million, operating income of JPY 2,900 million and net income was JPY 1,850 million or JPY 101.69 per diluted share.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4549:JP ¥1,734.00 JPY -11.00

4549 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4549.
View Industry Companies
 

Industry Analysis

4549

Industry Average

Valuation 4549 Industry Range
Price/Earnings 16.4x
Price/Sales 1.1x
Price/Book 1.3x
Price/Cash Flow 19.3x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EIKEN CHEMICAL CO LTD, please visit www.eiken.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.